Olanzapine ( DrugBank: Olanzapine )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
2	筋萎縮性側索硬化症	2
8	ハンチントン病	1

2. 筋萎縮性側索硬化症

臨床試験数 : 645 / 薬物数 : 589 - (DrugBank : 163) / 標的遺伝子数 : 150 - 標的パスウェイ数 : 225

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00876772 (ClinicalTrials.gov)	March 2011	6/4/2009	Olanzapine for the Treatment of Appetite Loss in Amyotrophic Lateral Sclerosis (ALS)	Randomized, Placebo-controlled Parallel Group Study for the Evaluation of an Oral Dose of 10mg Olanz ...	Amyotrophic Lateral Sclerosis (ALS)	Drug: Olanzapine	Charite University, Berlin, Germany	NULL	Recruiting	18 Years	80 Years	Both	40	Phase 2/Phase 3	Germany
2	EUCTR2007-003775-39-DE (EUCTR)	29/10/2008	09/09/2008	Randomised, placebo-controlled parallel-group trial to evaluate an oral dose of 10 mg Olanzapin comb ...	Randomised, placebo-controlled parallel-group trial to evaluate an oral dose of 10 mg Olanzapin comb ...	patients with amyotrophic lateral sclerosis	Trade Name: Zyprexa INN or Proposed INN: OLANZAPINE	Charité – Universitätsmedizin Berlin	NULL	Not Recruiting			Female: yes Male: yes			Germany

臨床試験数 : 242 / 薬物数 : 205 - (DrugBank : 62) / 標的遺伝子数 : 85 - 標的パスウェイ数 : 159

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00632645 (ClinicalTrials.gov)	April 2009	29/2/2008	Neuroleptic and Huntington Disease Comparison of : Olanzapine, la Tetrabenazine and Tiapride	Neuroleptic and Huntington Disease. Comparison of : Olanzapine, la Tetrabenazine and Tiapride. A Mul ...	Huntington Disease	Drug: Olanzapine;Drug: Xenazine;Drug: Tiapridal	Assistance Publique - Hôpitaux de Paris	NULL	Completed	18 Years	N/A	All	180	Phase 3	France